Spontaneous community-acquired PVL-producing Staphylococcus aureus mediastinitis in an immunocompetent adult - a case report

BMC Infect Dis. 2020 May 19;20(1):354. doi: 10.1186/s12879-020-05076-6.

Abstract

Background: Mediastinitis caused by hematogenous spread of an infection is rare. We report the first known case of community-acquired mediastinitis from hematogenous origin in an immunocompetent adult. This rare invasive infection was due to Panton-Valentine Leucocidin-producing (PVL+) methicillin-susceptible Staphylococcus aureus (MSSA).

Case presentation: A 22-year-old obese man without other medical history was hospitalized for febrile precordial chest pain. He reported a cutaneous back abscess 3 weeks before. CT-scan was consistent with mediastinitis and blood cultures grew for a PVL+ MSSA. Intravenous clindamycin (600 mg t.i.d) and cloxacillin (2 g q.i.d.), secondary changed for fosfomycin (4 g q.i.d.) because of a related toxidermia, was administered. Surgical drainage was performed and confirmed the presence of a mediastinal abscess associated with a fistula between the mediastinum and right pleural space. All local bacteriological samples also grew for PVL+ MSSA. In addition to clindamycin, intravenous fosfomycin was switched to trimethoprim-sulfamethoxazole after 4 weeks for a total of 10 weeks of antibiotics.

Conclusions: We present the first community-acquired mediastinitis of hematogenous origin with PVL+ MSSA. Clinical evolution was favorable after surgical drainage and 10 weeks of antibiotics. The specific virulence of MSSA PVL+ strains played presumably a key role in this rare invasive clinical presentation.

Keywords: Community-acquired mediastinitis; MSSA; Panton-valentine Leucocidin.

Publication types

  • Case Reports

MeSH terms

  • Abscess / drug therapy
  • Abscess / microbiology
  • Abscess / surgery
  • Anti-Bacterial Agents / therapeutic use
  • Anti-Infective Agents, Urinary / therapeutic use
  • Bacterial Toxins / analysis*
  • Clindamycin / therapeutic use
  • Community-Acquired Infections / diagnosis*
  • Community-Acquired Infections / drug therapy
  • Drainage
  • Exotoxins / analysis*
  • Humans
  • Immunocompetence*
  • Leukocidins / analysis*
  • Male
  • Mediastinitis / diagnosis*
  • Mediastinitis / drug therapy
  • Mediastinitis / immunology
  • Mediastinitis / microbiology*
  • Staphylococcal Infections / diagnosis*
  • Staphylococcal Infections / drug therapy
  • Staphylococcal Infections / immunology
  • Staphylococcal Infections / microbiology
  • Staphylococcus aureus / metabolism*
  • Treatment Outcome
  • Trimethoprim, Sulfamethoxazole Drug Combination / therapeutic use
  • Young Adult

Substances

  • Anti-Bacterial Agents
  • Anti-Infective Agents, Urinary
  • Bacterial Toxins
  • Exotoxins
  • Leukocidins
  • Panton-Valentine leukocidin
  • Clindamycin
  • Trimethoprim, Sulfamethoxazole Drug Combination